Most Read Articles
Stephen Padilla, 4 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

03 Aug 2020
Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.

Product Highlight - Vocinti

27 Sep 2019
First-In-Class Potassium Competitive Acid Blocker (P-CAB) in Malaysia5
To meet the needs of patients with acid-related disorders, Vocinti offers:
• Immediate Effect1
• Strong Acid Suppression2
• Sustained Acid Suppression3
• Durable Effect4
• Well Tolerated4

References:
1. Oshima et al. Aliment Pharmacol Ther. 2019;49:140–146
2. Sakurai Y, et al. Aliment Pharmacol Ther 2015;42:719-30.e94
3. Jenkins H, et al. Aliment Pharmacol Ther 2015;41:636-48.
4. Ashida K, et al. Aliment Pharmacol Ther 2016;43:240-51
5. Echizen et al. Clin Pharmacokinet. 2016 Apr;55(4):409-18


Full prescribing information is available upon request.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 4 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

03 Aug 2020
Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.